RecruitingPhase 4NCT07745062

The Effectiveness of Systane PRO Preservative Free Verses Blink Triple Care Preservative Free

The Effectiveness of Systane PRO Preservative Free Verses Blink Triple Care Preservative Free in Providing Relief From Multiple Symptoms of Dry Eye Disease, and Its Impact on Daily Functioning and Overall Comfort in Dry Eye Subjects


Sponsor

Gordon Schanzlin New Vision

Enrollment

30 participants

Start Date

Jul 17, 2026

Study Type

INTERVENTIONAL

Conditions

Summary

The goal of this investigational study is to determine if Systane PRO Preservative Free is non-inferior to BLINK TRIPLE CARE in the clinically significant improvement of signs and symptoms of dry eye in patients over 4 weeks.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Blink tears and a drug called Systane PRO for people with dry eye disease (ded). The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGSystane PRO

Administer Systane Pro PF QID OU over a period of 30 days

DRUGBlink tears

Administer Blink Triple Care PF QID OU over a period of 30 days


Locations(1)

Gordon Schanzlin New Vision Institute

La Jolla, California, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07745062


Related Trials